AZN

#5576
AstraZeneca PLC
202.75 USD
-0.61%
Сектор: Здравоохранение
Базовая: USD
Валюта прибыли: USD
Дневной диапазон
202.30
202.92
Годовой диапазон
66.16
212.71
Дневное изменение
-0.61%
Месячное изменение
+6.27%
6-месячное изменение
+139.83%
Годовое изменение
+203.56%
Предыдущее закрытие
204.00
Открыть
202.59
Bid
Ask
Минимум
202.30
High
202.92
Объем
298
Открыть полный график

Financials

Обзор Отчетность Статистика Дивиденды
Квартал Год
  • Market Capitalization N/A
  • Employee 96 K
  • Founded 1999
  • CEO Pascal Soriot
  • Website www.astrazeneca.com
  • Headquarter United Kingdom
  • FIGI BBG000BZ0DK8
  • Industry Technology
Общий доход
Чистая прибыль
Общий долг
Свободный денежный поток
Денежные средства и эквиваленты

AstraZeneca PLC - American Depositary Shares

AstraZeneca plc is a Swedish-British multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, UK. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. The company was founded in 1999 through the merger of the Swedish Astra AB and the British Zeneca Group. Zeneca shareholders received 53.5% of the shares, while Astra shareholders received the remaining 46.5%. Its portfolio includes primary and speciality care, coverage for rare diseases, and a robust global presence across various regions. Since the merger it has been among the world's largest pharmaceutical companies and has made numerous corporate acquisitions, including Cambridge Antibody Technology, MedImmune, Spirogen and Definiens. It has its research and development concentrated in three strategic centres: Cambridge, UK; Gothenburg, Sweden; and Gaithersburg, Maryland, US. AstraZeneca traces its earliest corporate history to 1913, when Astra AB was formed by a large group of doctors and apothecaries in Södertälje.

Новости